A UAB researcher focusing on the epigenetics of drug abuse wins a significant funding award from the National Institutes of Health.
Published in Faculty Excellence
Male and female mice use different immune cells to process chronic pain, indicating that different therapies for different genders could better target the problem.
The drug inhibits the activity of a kinase enzyme called LRRK2, and it showed no pathology in rat lungs, kidneys or livers.
Hundreds of students will present academic pursuits in cutting-edge research topics.
Published in Student Experience
UAB offers two national clinical trials with customized treatment for lung cancer patients.
Published in Focus on Patient Care
UAB’s David Pollock, Ph.D., recently visited Cuba with a delegation from the American Physiological Society to sign a historic agreement for research collaboration with Cuban counterparts.
Published in Faculty Excellence
Boni Elewski, M.D., and Wendy Cantrell, DNP, pursue research and therapies that bring new drugs to market and change patients’ lives.
Published in Focus on Patient Care
This improvement in cognition persists despite a high-glycemic-index diet, a possible risk factor for Alzheimer’s.
Three-year grant establishes consortium to better organize and support collaborative research related to the loss of functional beta cell mass in type 1 diabetes.

Neuron-derived microRNAs obtained from blood samples may correlate with treatment response and could aid the search for new therapeutics.

The Aura cloud computing system, designed by UAB computer scientist Ragib Hasan, Ph.D., could turn the Internet of Things into the Internet of Cha-ching.
A UAB study to explore the effects of intraocular pressure fluctuations on glaucoma receives federal funding.
Published in Faculty Excellence
A UAB study sheds new light on the epigenetics of memory formation and memory loss in patients with epilepsy, and the discovery may have implications for many other memory disorders.
UAB presents preliminary data indicating a significant savings in cancer costs by using a novel lay navigation program.
Published in Focus on Patient Care
A study of the rapid evolution of the insulin-signaling molecular network that regulates growth, reproduction, metabolism and aging lays important groundwork for future studies.
A new study from UAB suggests that the effect of genetic variants on warfarin dose differs by race – a step towards personalized medicine.
UAB researchers find a chemical pathway — a glutamate transporter — that may be causing seizures and shorten survival rates for patients with brain tumors.
As UAB’s strategic planning process continues, top CAS priorities include undergraduate program development, and recruitment, retention and graduation; building a new College of Arts and Sciences building and renovating Campbell Hall; and growing leadership and personnel.
Janet M. Turan, Ph.D., associate professor in the UAB School of Public Health, has been awarded an R01 grant from the National Institutes of Health to complete the study.
The VORLab will study the effects of injuries sustained in football and other contact sports on balance, eye movement and vision to improve diagnostic tools and promote recovery.
Page 1 of 56

News You Can Use

 
 
Back to Top